Emergence of AI Healthcare Policy Amidst Fragme...

By João L. Carapinha

May 25, 2026

The rapid evolution of AI Healthcare Policy is evident in the Health & AI Policy Index (HAPI) snapshot from January 1, 2026, which catalogs 240 policies illustrating swift expans...
Hepcludex HDV Approval: A Breakthrough in Chronic Hepatitis Delta Treatment
TrumpRx.gov Expansion: Enhancing Medication Price Transparency and Competition
First-in-Human Trials: Foundations and Market Implications in Health Economics
PSA Response Improvement: Promising Data from Pluvicto in mHSPC Treatment
Pharmaceutical Onshoring Agreements: Navigating Tariff Relief and National Se...
Core Recommendations for Equitable Digital Medicine Access
Bladder Cancer Treatment Impact: Barriers to Quality of Life in Patients
Global Growth and Challenges in Pharmacy Vaccination Training
Unlocking the Benefits of Cardiovascular Health Checks in EU Prevention Strat...
MFN Drug Pricing Savings: Projected $593 Billion in U.S. Healthcare Savings O...
Navigating the Challenges of Patient-Centered AI Systems in Postpartum Depres...
Amgen Financial Results: Q1 2026 Performance Breakdown